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A 54-year-old woman was referred to our Korsakoff Center because of extensive cognitive
problems following acute Wernicke’s encephalopathy (WE). She had a relatively short his-
tory of alcohol abuse and was found lying on the floor in her home by her son. After 5 days
without treatment, she was diagnosed with WE in a general hospital. During the course
of the disease, minimal change to the acute situation occurred, with chronic confusion,
attention deficits, and incoherent behavior symptoms most notable unlike classical Kor-
sakoff’s syndrome. Neuropsychological assessment after 4 and 16 months after admission
to the hospital revealed global cognitive decline, with striking impairments in attentional,
executive, and memory functions.The present case study suggests that the state of confu-
sion and the neuropsychological symptoms in WE can become chronic in case of very late
treatment. We therefore recommend that confused alcoholics should receive appropriate
parenteral thiamine according to the current clinical standards.
Keywords:Wernicke’s encephalopathy, Korsakoff’s syndrome, confusion, delirium, dementia, amnestic, cognitive
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INTRODUCTION
Wernicke’s encephalopathy (WE) is an acute neuropsychiatric syn-
drome resulting from vitamin B1 (thiamine) deficiency (1). The
syndrome is characterized by confusion, attentional disorders,
incoherence, eye-movement disorders, and ataxia, although fre-
quently only one or two characteristics are present (2–4). In the
industrialized world, most patients with WE have a background
of chronic alcoholism and self-neglect (5). WE requires immedi-
ate treatment with intravenous or intramuscular thiamine. When
patients with WE are promptly treated with parenteral thiamine
replacement therapy, this is a life-saving measure that also may
prevent the development of chronic brain damage (6). When WE
is left untreated or is inappropriately treated with either low doses
of thiamine or oral thiamine replacement therapy, this may result
in a life-threatening situation with mortality rates up to 20% of
the patients (4). In the patients who survive with this lack of treat-
ment, varying degrees of brain damage develop, although the exact
course of illness is not well-understood (7). Progression into a
well-known form of chronic amnesia, Korsakoff ’s syndrome (KS),
is not uncommon [Ref. (8), see Figure 1]. Usually, KS follows WE
when acute confusion improves within one to a couple of weeks.
Primary characteristics of this improvement include the ability
to concentrate for a longer time, less incoherence in behavior,
and clear consciousness over the course of the day despite severe
amnesia (8–10).
Descriptions of cases of WE where the symptoms do not
improve rapidly are scarce and often restricted to the acute sit-
uation. Examples of such cases have been described in the course
of World War II following starvation in prisoners of war (12).
Descriptions of the cognitive sequelae in the course of prolonged
confusion following WE are currently not available in the liter-
ature. Such neuropsychiatric descriptions of severe cases of WE
are crucial, however, as it will give insight in the severity of the
syndrome. Despite the current standards of emergency care in the
industrialized world, a vast majority of patients with WE are inad-
equately managed, resulting in patients who show confusion for a
prolonged time (13–15). Here, we present a case study that illus-
trates the cognitive and behavioral characteristics, including signs
of confusion, of a patient who was admitted to our clinic with
untreated WE. Neuropsychological assessment revealed striking
cognitive impairments unlike KS. Importantly, the initial cognitive
and neuropsychiatric problems did not resolve in time, providing
an example of a patient with acute WE that became chronic.
CASE REPORT
BIOGRAPHICAL HISTORY
According to members of the family, the patient functioned inde-
pendently prior to the neurological problems. The son of the
patient visited her several times a week. In her house she was able
to manage the household, despite her alcohol abuse. The amount
of alcohol she consumed varied between one and three bottles of
wine each day. She divorced 12 months prior to diagnosis with
WE. Up until 6 months before admission, the patient worked in a
reel kitchen in a hospital. The last month, she had not been eat-
ing well and consumed alcohol throughout the day. He told that
the patient did not feel like eating, but still spoke about things she
wanted to undertake to manage her alcoholism. The day before she
was found, she had a telephone call with her son. The son reported
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FIGURE 1 | Evolution ofWernicke’s encephalopathy as proposed by
Harper et al. (3) and Day et al. (11). See Kopelman et al. (8) for a review.
that the telephone call included a regular exchange of information
without any striking exchange of information.
MEDICAL HISTORY
Our patient is a 54-year-old woman with a 7-year history of alco-
hol abuse. The patient did not have a psychiatric history. She was
found in her house on the floor of the living room. According
to reports of her son who found her, she was unable to move her
legs, showed odd eye movements, had visual hallucinations of food
lying around her, talked nonsense, and was incontinent of urine.
After a visit of a general practitioner to her house, her son was
told to give his mother rest. After 5 days and no apparent change
to her situation, a visiting psychiatrist referred her to the hospi-
tal where she was diagnosed with WE and underwent a therapy
of oral thiamine treatment. Subsequently, the patient was admit-
ted to a department of an addiction center where she stayed for
almost 8 months. Here, her behavior was described as incoherent
and confused. She showed a compulsion to visit the toilet regularly
and to frequently ask the nursing staff for cigarettes. After her stay
in the addiction center, she was referred to our clinic for patients
with KS.
METHODS
Four months after she was found, a neuropsychological evaluation
was performed (T1) in the addiction center. Sixteen months after
the first evaluation, the cognitive functions were re-evaluated (T2).
Results of the first and second neuropsychological evaluation are
displayed in Table 1. A chronic KS reference group is displayed in
the last column. The results for the reference group were adopted
from group studies on chronic KS patients as displayed in Table 1.
The first neuropsychological evaluation consisted of the Wechsler
Adult Intelligence Scale-III (16), the Raven Standard Progressive
Matrices (17), Word-Fluency Animals and Professions (18), Digit
Span Forward and Backward (16), Rey’s Complex Figure Task
(19), Wechsler Memory Scale-R, Hooper Visual Integration (20),
Stroop (21), Trail Making Task (22), and the Behavioral Assess-
ment of Dysexecutive Syndrome Key Search Task. The second
neuropsychological assessment consisted of the Mini Mental State
Examination, the Cognitive Screening Task (23), Word-Fluency
Animals, Digit Span Forward and Backward, Trail Making Task,
the Visual Association Test (24), Rey’s Complex Figure Task and
the Frontotemporal Dementia Rating Scale (25). The patient was
informed by the first author and asked whether she was willing
to participate. Written informed consent was obtained from the
legal representative. The procedure was performed in accordance
with the guidelines of the Declaration of Helsinki and guidelines
for recruitment of incompetent patients [cf. Ref. (26)].
RESULTS
OBSERVATIONS AND NEUROPSYCHOLOGICAL ASSESSMENT ON T1
Qualitative observations on T1 showed a consistent pattern of
striking impairments. Mental confusion was reported, with a
preference to keep asking for cigarettes, high distractibility, and
disorganization of behavior. The patient would frequently walk
away during a conversation. Her behavior appeared severely dis-
organized. While she was sitting behind a computer performing
Solitaire, she would move her legs up and down vigorously, possi-
bly as a symptom of late-stage WE (4). Moreover, she would walk
into her room, undress, lay in her bed for just a couple of minutes.
Hereafter she would dress herself, ask the nursing staff for ciga-
rettes, smoke and walk into her room to undress and lay in her bed
for just a couple of minutes, and dress again. During lunch and
dinner time, she walked into the room and would just eat one bite
and leave the room instantly. During the nights, she would ask the
staff for food. According to nursing staff reports, she did not show
evidence of positive nor negative emotions during the day.
The left column of Table 1 depicts the test scores on neuropsy-
chological assessment after 4 months after admission to the hos-
pital. Initially (T1), her performance on the neuropsychological
assessment was consistent with a profile of cognitive deterioration,
showing impaired performance on tests for attention, orientation,
intelligence, word-fluency, working memory, long-term memory,
construction, and executive functioning, compared to healthy par-
ticipants. Importantly, the cognitive profile was severely affected
by the attentional disorders, consistent with an acute WE. Neu-
ropsychological performance ranged from moderate to severe
impairment, with the exception of perceptual abilities. The ref-
erence groups of KS patients had an impaired performance on
orientation, long-term memory, and executive functioning. On
tasks intended to index orientation, word-fluency, working mem-
ory, visuoconstruction, and intelligence, the performance of the
patient was more than 1 SD below the average score in the KS
reference groups. This suggests that both the nature and extent of
cognitive disorders in the case study were remarkably serious.
OBSERVATIONS AND NEUROPSYCHOLOGICAL ASSESSMENT ON T2
Qualitative observations of confused behavior lasted during her
stay in our Korsakoff clinic without showing any signs of improve-
ment or deterioration over time. The patient appeared as highly
distractible if the team members were able to motivate her. She
would frequently undress and redress herself in her room.
The right column of Table 1 depicts the test scores on neu-
ropsychological assessment after 16 months after admission to the
hospital. The pattern of cognitive functioning was consistent to
the pattern of observed cognitive dysfunction at T1. The patient
showed similar performance on the cognitive tasks: impaired
Frontiers in Psychiatry | Neurodegeneration May 2014 | Volume 5 | Article 59 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oudman et al. Chronic Wernicke’s encephalopathy
Table 1 |Test results of neuropsychological assessment after 4 and 16months after admission to the hospital in our case and a KS reference
group.
Case: neuropsychological
assessment 1 – 4months
after admission
Case: neuropsychological
assessment 2 – 16months
after admission
Cognitive domain Test Patient Patient compared
to KS reference
group
Test Patient Patient compared
to KS reference
group
KS reference
group
Orientation Time and place
(MOCA)
2** z =−1.1 Time and place
(MOCA)
2** z =−1.1 3.6 (1.5)a
Global cognitive
functioning
MMSE¶ 21/30** z =−0.6 22.8 (3)b
Cognitive Screening
Test¶
10/20** N.A.
Language Word-Fluency
Animals (1 min)¶
15** z =−1.1 Word-Fluency
Animals (1 min)¶
10** z =−1.3 36 (20)c
Word-Fluency
Professions (1 min)¶
13** z =−1.5 35 (15)c
Working memory Digit span¶ 5* z =−3.9 Digit span¶ 8* z =0.4 7.7 (0.7)b
Long-term
memory
Rey’s complex figure
recall¶
0** z =−0.9 Rey’s complex figure
recall§
0** z =−0.9 2.5 (2.7)d
WMS-R logic
memory¶
7** 6 (N.A.)e
WMS-R visual
reproduction¶
0** Visual Association
Test§
0** N.A.
Visuoperception Hooper visual
integration
15 N.A.
Visuoconstruction Rey’s complex figure
(copy)§
13* z =−2.9 Rey’s complex figure
(copy)
11* z =−3.2 29.8 (5.8)b
Attention Stroop I§ 3** z =−0.5 TMT A§ 4** z =−0.6 12.9 (18.3)c
Stroop interference
score (III to II)§
42 z =0.8 26.5 (18.9)c
TMT A§ 7* z=−0.5 24.8 (32.5)c
TMT interference
score (B–A)§
24* z =−0.3 32.2 (29.5)c
Executive
Functioning
BADS key searchU 1** z =−0.8 2.0 (1.2)c
FDS Rating Scale 5/30** N.A.
Intelligence WAIS-III 70** z =−2.4 104 (14)e
WAIS-III verbal scale 74** z =−2.4 107 (14)e
WAIS-III
performance scale
65** z =−2.3 100 (15)e
N.A.=not available, *Below average performance compared to the healthy control norm group (≤16th percentile). **Impaired performance compared to the healthy
control norm group (≤6th percentile). ¶Raw score; §percentile score; Uequivalent score (max 4).
aA reference group of 20 patients with KS, with an average age of 57.6 (8.7) years (27).
bA reference group of 16 patients with KS, with an average age of 58.9 (7.1) years (28).
cA reference group of 19 patients with KS, with an average age of 58.8 (8.8) years (29).
dA reference group of 20 patients with KS, with an average age of 59.7 (5.7) years (30).
eA reference group of 30 patients with KS, with an average age of 60.5 (10.0) years (31).
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performance on tests for orientation, intelligence, word-fluency,
working memory, long-term memory,construction,attention,and
executive functioning compared to healthy participants. Atten-
tional problems were as striking as at T1. The cognitive pat-
tern was stable compared to T1, whereas improvement in case
of KS is to be expected based on the available literature (see
Figure 1).
DISCUSSION
The patient in the present case report showed a distinctive chronic
pattern of cognitive and neuropsychiatric impairments in the
course of severe WE. Signs of confusion and incoherent behav-
ior were evident and did not resolve in time. Cognitive disorders
in attention, long-term memory, working memory, visuocon-
struction, and word-fluency became apparent both after 4 and
16 months after admission to the hospital. Importantly, the atten-
tional deficits severely affected the cognitive profile on both neu-
ropsychological evaluations. Compared to a KS reference group,
the patient showed a broader range of severe cognitive impair-
ments. The patient was able to function independently up to the
point that she developed WE. The cognitive and neuropsychiatric
problems were in accordance to the acute symptoms of WE and
did not improve over the course of her stay in the clinic, suggesting
that her WE became chronic.
Wernicke’s encephalopathy is a life-threatening condition fol-
lowing acute thiamine deficiency (5). Whereas a large deal of
research on WE has been devoted to successful treatment of WE
in the acute phase, descriptions of cases where confusion does not
improve rapidly are currently lacking. This is striking given that in
clinical practice, WE is undertreated and patients are still admitted
to general or psychiatric hospitals with prolonged states of con-
fusion (13–15). Moreover, WE is potentially fatal in about 20%
of the patients (8). The present case study suggests that WE can
not only result in a life-threatening acute situation, but also in a
chronic form of WE, incorporating a chronic state of confusion
and disorganized behavior. The severity of the neuropsychiatric
symptoms makes a patient in need of lifelong care.
A possible explanation for why the patient in the current case
study developed a severe chronic pattern of cognitive problems
could be the late hospital admission and inadequate treatment
with thiamine replacement therapy. Although the patient was
found lying on the floor with abundant symptoms of neurological
disease (e.g., odd eye movements, visual hallucinations, inconti-
nence), she was not admitted to the hospital in the first 5 days
and received no treatment during this period. Since severe cogni-
tive disorders are the consequence of untreated or under-treated
thiamine deficiency, the patient should have received thiamine
replacement therapy instantly (7). In the present case, WE was
eventually diagnosed in the hospital, after which oral thiamine
supplementation started. This time point of thiamine supple-
mentation is regarded as a very late compensation for thiamine
deficiency (13). Moreover, oral replacement therapy is less effective
than parenteral replacement therapy (4).
Given that the prognosis of WE is known to depend on
the speed of compensating the deficiency in thiamine (14) and
the severe chronic cognitive disturbance associated with chronic
WE observed in the present study, our results indicate that
an active treatment policy is needed to avoid severe chronic
neuropsychiatric symptoms. Current treatment standards suggest
that parenteral (intravenous or intramuscular thiamine should be
given 200 up to 500 mg three times daily until symptoms of acute
WE resolute (32). In order to prevent severe and chronic cognitive
disorders, physicians should have a high index of suspicion for WE
and dose parenteral thiamine accordingly (7).
Although the patient in our case study had a history of alco-
hol abuse, the neurocognitive symptoms had an acute onset as
reported in WE, which makes alcohol dementia an implausible
explanation for the severe acute cognitive problems (33). More-
over, the cognitive problems remained stable over a period of
16 months, unlike progressive dementia. Dissimilar to KS, the
patient had chronic problems in her attentional function, working
memory, visuoconstruction, and word-fluency functions.
In conclusion, the current case study illustrates the cognitive
and behavioral characteristics of a patient who was admitted to
our clinic with untreated WE. Our description provides the first
report on a patient with prolonged states of confusion follow-
ing WE, suggesting that WE can become chronic in case of late
thiamine replacement therapy.
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